Conférences
le (1h9m45s)
Résultats de recherche
Trier par :
Nombre de programmes trouvés : 5426
Conférences
le (26m5s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : Different doses, different indications? (Freek VERHEUGT)
... development of new antithrombotic agents is a challenging area of cardiovascular medicine.These agents generally have a narrow therapeutic margin, and it is often difficult to find the optimal balance between efficacy (reduction of ischemic events) and safety... Voir la vidéo
Conférences
le (13m7s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Efthymios DELIARGYRIS)
... development of new antithrombotic agents is a challenging area of cardiovascular medicine.These agents generally have a narrow therapeutic margin, and it is often difficult to find the optimal balance between efficacy (reduction of ischemic events) and safety... Voir la vidéo
Conférences
le (52m37s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Faiez ZANNAD)
... development of new antithrombotic agents is a challenging area of cardiovascular medicine.These agents generally have a narrow therapeutic margin, and it is often difficult to find the optimal balance between efficacy (reduction of ischemic events) and safety... Voir la vidéo
Conférences
le (9m33s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Krishna PRASAD)
... development of new antithrombotic agents is a challenging area of cardiovascular medicine.These agents generally have a narrow therapeutic margin, and it is often difficult to find the optimal balance between efficacy (reduction of ischemic events) and safety... Voir la vidéo
Conférences
le (7m9s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : Industry viewpoint (Joerg KOGLIN)
... development of new antithrombotic agents is a challenging area of cardiovascular medicine.These agents generally have a narrow therapeutic margin, and it is often difficult to find the optimal balance between efficacy (reduction of ischemic events) and safety... Voir la vidéo
Conférences
le (33m2s)
Fancying Nature: the posterity of Joseph Addison’s ‘Pleasures’ in English Enlightenment culture / Frédéric Ogée
...Fancying Nature: the posterity of Joseph Addison’s ‘Pleasures’ in English Enlightenment culture / Frédéric Ogée, in colloque international "Fancy‒Fantaisie‒Capriccio. Diversions and Distractions in the Eighteenth Century" organisé, sous la... Voir la vidéo
Conférences
le (48m39s)
Reflecting on a theoretical approach from a networking perspective: the case of the documentational approach to didactics
...One decade ago, the documentational approach to didactics (Gueudet, Pepin, & Trouche, 2012) was just emerging. Since then, it has developed and matured, benefitting from the collaborative work and contributions of researchers with different... Voir la vidéo
Vidéocours
le (8m6s)
Heinrich Events - Sylvain Huon
...What are the Heinrich events? Nature of sediment deposited during Heinrich events. Trajectory of the ice and icebergs in the North Atlantic. Characteristics of the six Heinrich events in the North Atlantic. Origin of the Heinrich sediment levels. In... Voir la vidéo
Conférences
le (1h7s)
